168 related articles for article (PubMed ID: 30286617)
1. Performance evaluation of the GastroPlus
Zhang F; Bartels M; Clark A; Erskine T; Auernhammer T; Bhhatarai B; Wilson D; Marty S
SAR QSAR Environ Res; 2018 Nov; 29(11):875-893. PubMed ID: 30286617
[TBL] [Abstract][Full Text] [Related]
2. A framework for application of quantitative property-property relationships (QPPRs) in physiologically based pharmacokinetic (PBPK) models for high-throughput prediction of internal dose of inhaled organic chemicals.
Chebekoue SF; Krishnan K
Chemosphere; 2019 Jan; 215():634-646. PubMed ID: 30347358
[TBL] [Abstract][Full Text] [Related]
3. Predictions of tissue concentrations of myclobutanil, oxyfluorfen, and pronamide in rat and human after oral exposures via GastroPlus
Zhang F; Erskine TC; McClymont EL; Moore LM; LeBaron MJ; McNett D; Marty SS
SAR QSAR Environ Res; 2024 Apr; 35(4):285-307. PubMed ID: 38588502
[TBL] [Abstract][Full Text] [Related]
4. IMI - Oral biopharmaceutics tools project - Evaluation of bottom-up PBPK prediction success part 4: Prediction accuracy and software comparisons with improved data and modelling strategies.
Ahmad A; Pepin X; Aarons L; Wang Y; Darwich AS; Wood JM; Tannergren C; Karlsson E; Patterson C; Thörn H; Ruston L; Mattinson A; Carlert S; Berg S; Murphy D; Engman H; Laru J; Barker R; Flanagan T; Abrahamsson B; Budhdeo S; Franek F; Moir A; Hanisch G; Pathak SM; Turner D; Jamei M; Brown J; Good D; Vaidhyanathan S; Jackson C; Nicolas O; Beilles S; Nguefack JF; Louit G; Henrion L; Ollier C; Boulu L; Xu C; Heimbach T; Ren X; Lin W; Nguyen-Trung AT; Zhang J; He H; Wu F; Bolger MB; Mullin JM; van Osdol B; Szeto K; Korjamo T; Pappinen S; Tuunainen J; Zhu W; Xia B; Daublain P; Wong S; Varma MVS; Modi S; Schäfer KJ; Schmid K; Lloyd R; Patel A; Tistaert C; Bevernage J; Nguyen MA; Lindley D; Carr R; Rostami-Hodjegan A
Eur J Pharm Biopharm; 2020 Nov; 156():50-63. PubMed ID: 32805361
[TBL] [Abstract][Full Text] [Related]
5. Prediction of Oral Pharmacokinetics Using a Combination of In Silico Descriptors and In Vitro ADME Properties.
Kosugi Y; Hosea N
Mol Pharm; 2021 Mar; 18(3):1071-1079. PubMed ID: 33512165
[TBL] [Abstract][Full Text] [Related]
6. In Silico Modeling of Gastrointestinal Drug Absorption: Predictive Performance of Three Physiologically Based Absorption Models.
Sjögren E; Thörn H; Tannergren C
Mol Pharm; 2016 Jun; 13(6):1763-78. PubMed ID: 26926043
[TBL] [Abstract][Full Text] [Related]
7. Prediction of tissue and urine concentrations of 2-phenoxyethanol and its metabolite 2-phenoxyacetic acid in rat and human after oral and dermal exposures via GastroPlus
Zhang F; LeBaron MJ; Marty MS
SAR QSAR Environ Res; 2022 May; 33(5):323-339. PubMed ID: 35301938
[TBL] [Abstract][Full Text] [Related]
8. Using Chemical Structure Information to Develop Predictive Models for
Pradeep P; Patlewicz G; Pearce R; Wambaugh J; Wetmore B; Judson R
Comput Toxicol; 2020 Nov; 16():. PubMed ID: 34124416
[TBL] [Abstract][Full Text] [Related]
9. Improved Human Pharmacokinetic Prediction of Hepatically Metabolized Drugs With Species-Specific Systemic Clearance.
Horiuchi K; Ohnishi S; Matsuzaki T; Funaki S; Watanabe A; Mizutare T; Matsumoto S; Nezasa KI; Hasegawa H
J Pharm Sci; 2018 May; 107(5):1443-1453. PubMed ID: 29331382
[TBL] [Abstract][Full Text] [Related]
10. Assessing Toxicokinetic Uncertainty and Variability in Risk Prioritization.
Wambaugh JF; Wetmore BA; Ring CL; Nicolas CI; Pearce RG; Honda GS; Dinallo R; Angus D; Gilbert J; Sierra T; Badrinarayanan A; Snodgrass B; Brockman A; Strock C; Setzer RW; Thomas RS
Toxicol Sci; 2019 Dec; 172(2):235-251. PubMed ID: 31532498
[TBL] [Abstract][Full Text] [Related]
11. Application of physiologically-based toxicokinetic modelling in oral-to-dermal extrapolation of threshold doses of cosmetic ingredients.
Gajewska M; Worth A; Urani C; Briesen H; Schramm KW
Toxicol Lett; 2014 Jun; 227(3):189-202. PubMed ID: 24731971
[TBL] [Abstract][Full Text] [Related]
12. Designing QSARs for Parameters of High-Throughput Toxicokinetic Models Using Open-Source Descriptors.
Dawson DE; Ingle BL; Phillips KA; Nichols JW; Wambaugh JF; Tornero-Velez R
Environ Sci Technol; 2021 May; 55(9):6505-6517. PubMed ID: 33856768
[TBL] [Abstract][Full Text] [Related]
13.
Kamiya Y; Handa K; Miura T; Yanagi M; Shigeta K; Hina S; Shimizu M; Kitajima M; Shono F; Funatsu K; Yamazaki H
Chem Res Toxicol; 2021 Feb; 34(2):507-513. PubMed ID: 33433197
[TBL] [Abstract][Full Text] [Related]
14. Impact of Plasma Protein Binding in Drug Clearance Prediction: A Data Base Analysis of Published Studies and Implications for In Vitro-In Vivo Extrapolation.
Francis LJ; Houston JB; Hallifax D
Drug Metab Dispos; 2021 Mar; 49(3):188-201. PubMed ID: 33355201
[TBL] [Abstract][Full Text] [Related]
15. An Intuitive Approach for Predicting Potential Human Health Risk with the Tox21 10k Library.
Sipes NS; Wambaugh JF; Pearce R; Auerbach SS; Wetmore BA; Hsieh JH; Shapiro AJ; Svoboda D; DeVito MJ; Ferguson SS
Environ Sci Technol; 2017 Sep; 51(18):10786-10796. PubMed ID: 28809115
[TBL] [Abstract][Full Text] [Related]
16. Application of PBPK modeling to predict human intestinal metabolism of CYP3A substrates - an evaluation and case study using GastroPlus.
Heikkinen AT; Baneyx G; Caruso A; Parrott N
Eur J Pharm Sci; 2012 Sep; 47(2):375-86. PubMed ID: 22759901
[TBL] [Abstract][Full Text] [Related]
17. A generic, cross-chemical predictive PBTK model with multiple entry routes running as application in MS Excel; design of the model and comparison of predictions with experimental results.
Jongeneelen FJ; Berge WF
Ann Occup Hyg; 2011 Oct; 55(8):841-64. PubMed ID: 21998005
[TBL] [Abstract][Full Text] [Related]
18. Evaluating In Vitro-In Vivo Extrapolation of Toxicokinetics.
Wambaugh JF; Hughes MF; Ring CL; MacMillan DK; Ford J; Fennell TR; Black SR; Snyder RW; Sipes NS; Wetmore BA; Westerhout J; Setzer RW; Pearce RG; Simmons JE; Thomas RS
Toxicol Sci; 2018 May; 163(1):152-169. PubMed ID: 29385628
[TBL] [Abstract][Full Text] [Related]
19. Semi-mechanistic physiologically-based pharmacokinetic modeling of clinical glibenclamide pharmacokinetics and drug-drug-interactions.
Greupink R; Schreurs M; Benne MS; Huisman MT; Russel FG
Eur J Pharm Sci; 2013 Aug; 49(5):819-28. PubMed ID: 23806476
[TBL] [Abstract][Full Text] [Related]
20. Application of IVIVE and PBPK modeling in prospective prediction of clinical pharmacokinetics: strategy and approach during the drug discovery phase with four case studies.
Chen Y; Jin JY; Mukadam S; Malhi V; Kenny JR
Biopharm Drug Dispos; 2012 Mar; 33(2):85-98. PubMed ID: 22228214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
